SwingTrade Member Forum

[jaybird249]

Thanks. SCLN still has ENORMOUS upside IMO. Health care has been one of the hottest sectors lately and SCLN is an undiscovered gem. It is still trading at a price of a junior development stage biotech when it has turned the corner into a profitable drug company. SCLN has just scratched the surface of it enormous potential in China, and is expanding into many other countries. Plus, its new DC Bead drug will has even greater potential.. China will have more liver cancer cases than the rest of the world combined!

Tirn off your computer for a month.. I think SCLN will be $3 soon and that is still dirt cheap